Skip to search formSkip to main contentSkip to account menu

Azilsartan kamedoxomil

Known as: Potassium 3-(4'-((2-ethoxy-7-(((5-methyl-2-oxo-1,3-dioxol-4-yl)methoxy)carbonyl)-1H-benzimidazol-1-yl)methyl)biphenyl-2-yl)-5-oxo-1,2,4-oxadiazol-4(5H)-ide 
National Institutes of Health

Related topics

Related topics

4 relations

Narrower (1)

Edarbi

Broader (1)

azilsartan
azilsartan medoxomilazilsartan medoxomil 40 MG Oral Tablet [Edarbi]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Simultaneous spectrophotometric determination of Azilsartan Kamedoxomil and Cilnidipine in mixture
2018
2018
Stability Indicating Gradient Rp-Hplc Method for the Determination of Related Substances in Azilsartan Kamedoxomil Drug Substance
An efficient and selective RP-HPLC method was developed and validated for the determination of process and degradation impurities… 
2017
2017
Synthesis and characterization of related substances of Azilsartan Kamedoxomil
Abstract Azilsartan Kamedoxomil is an AT1-subtype angiotensin II receptor blocker (ARB). During the laboratory synthesis of… 
2016
2016
Azilsartan kaMedoxoMil solid dispersoid preparation and preparation method thereof
The invention relates to the field of pharmaceutical preparations and particularly discloses an Azilsartan kaMedoxoMil solid… 
2015
2015
A Rapid Novel HPLC Method for Estimation of Eight Related Compounds in Azilsartan Kamedoxomil and Identification of Degradation Compounds by Using LC-MS.
A novel, rapid, specific and stability-indicating reverse-phase high-performance liquid chromatography method was developed for… 
2015
2015
CommercialSynthesis of Azilsartan Kamedoxomil: AnAngiotensin II Receptor Blocker
2011
2011
New drugs. Azilsartan medoxomil, belimumab, and lurasidone hydrochloride.
Antihypertensive agent Azilsartan medoxomil (Edarbi—Takeda) is the eighth angiotensin II receptor blocker (ARB) to be marketed in… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)